Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Mousa

Showing results (51-60 of 138) with videos related to

Pageof 14
Sort By:
Journal of Thrombosis and Haemostasis : JTH|August 28, 2003
Antimetastatic effect of tinzaparin, a low-molecular-weight heparinA Amirkhosravi, S A Mousa, M Amaya, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 1988
Tolerance to tobacco smoke- and nicotine-induced analgesia in ratsS A Mousa, V J Aloyo, G R Van Loon
Journal of Pharmaceutical Sciences|January 10, 1998
Intranasal absorption of the platelet glycoprotein IIb/IIIa receptor antagonist, DMP 755, and the effect of anesthesia on nasal bioavailabilityM A Hussain, B J Aungst, R Kapil, et al.
British Journal of Pharmacology|June 1, 1990
Evaluation of the effect of azapropazone on neutrophil migration in regional myocardial ischaemia/reperfusion injury in rabbitsS A Mousa, R Brown, M J Thoolen, et al.
Journal of Neuroimmunology|April 3, 2001
beta-Endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissueS A Mousa, Q Zhang, N Sitte, et al.
Pharmacology & Therapeutics|May 24, 2014
Emerging therapies for Parkinson's disease: from bench to bedsideF I Tarazi, Z T Sahli, M Wolny, et al.
Expert Review of Neurotherapeutics|February 7, 2015
Asperger's syndrome: diagnosis, comorbidity and therapyF I Tarazi, Z T Sahli, J Pleskow, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 1996
Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesiaM Schafer, S A Mousa, Q Zhang, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1992
Myocardial anti-ischemic characteristics of a novel class of beta-adrenoceptor blockersS A Mousa, G Patil, M C Mayo, et al.
British Journal of Pharmacology|May 26, 2001
Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic: distinct binding profile for RoxifibanS A Mousa, J M Bozarth, U P Naik, et al.
Pageof 14

Showing results (51-60 of 138) with videos related to

Sort By:
Pageof 14
Journal of Thrombosis and Haemostasis : JTH|August 28, 2003
Antimetastatic effect of tinzaparin, a low-molecular-weight heparinA Amirkhosravi, S A Mousa, M Amaya, et al.
Pharmacology, Biochemistry, and Behavior|October 1, 1988
Tolerance to tobacco smoke- and nicotine-induced analgesia in ratsS A Mousa, V J Aloyo, G R Van Loon
Journal of Pharmaceutical Sciences|January 10, 1998
Intranasal absorption of the platelet glycoprotein IIb/IIIa receptor antagonist, DMP 755, and the effect of anesthesia on nasal bioavailabilityM A Hussain, B J Aungst, R Kapil, et al.
British Journal of Pharmacology|June 1, 1990
Evaluation of the effect of azapropazone on neutrophil migration in regional myocardial ischaemia/reperfusion injury in rabbitsS A Mousa, R Brown, M J Thoolen, et al.
Journal of Neuroimmunology|April 3, 2001
beta-Endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissueS A Mousa, Q Zhang, N Sitte, et al.
Pharmacology & Therapeutics|May 24, 2014
Emerging therapies for Parkinson's disease: from bench to bedsideF I Tarazi, Z T Sahli, M Wolny, et al.
Expert Review of Neurotherapeutics|February 7, 2015
Asperger's syndrome: diagnosis, comorbidity and therapyF I Tarazi, Z T Sahli, J Pleskow, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 1996
Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesiaM Schafer, S A Mousa, Q Zhang, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|March 1, 1992
Myocardial anti-ischemic characteristics of a novel class of beta-adrenoceptor blockersS A Mousa, G Patil, M C Mayo, et al.
British Journal of Pharmacology|May 26, 2001
Platelet GPIIb/IIIa binding characteristics of small molecule RGD mimetic: distinct binding profile for RoxifibanS A Mousa, J M Bozarth, U P Naik, et al.
Pageof 14